Online Investor Presentation and Q&A Session

/**/

RNS Number : 5617M Tern PLC 23 December 2025  

REACH - non regulatory announcement   23 December 2025   Tern Plc ("Tern" or the "Company") Online Investor Presentation and Q&A Session Tern Plc (AIM:TERN), the investment company specialising in supporting high growth, early-stage, disruptive Internet of Things ("IoT") technology businesses, is pleased to announce that the Company will be hosting an online presentation and Q&A session at 5.30 p.m. GMT on Wednesday 7 January 2026.   Presenting will be members of Tern's management team and management from Tern's portfolio companies, namely Device Authority and Talking Medicines. This session is open to all existing and prospective shareholders. Those who wish to attend should register via the following link where they will be provided with access details:   https://us02web.zoom.us/webinar/register/WN_ZJUb9TtIQruVWsQ_1HAMYA   Participants will have the opportunity to submit questions during the session, but questions are welcomed in advance and may be submitted prior to 3 p.m. GMT on 7 January 2026 to: tern@investor-focus.co.uk.   Enquiries  

Tern Plc Jane McCracken (Interim Non-Executive Chair)

via IFC Advisory

  Allenby Capital Limited (Nominated Adviser and Broker) Alex Brearley / Ashur Joseph (Corporate Finance) Kelly Gardiner (Sales and Corporate Broking)

  Tel: 0203 328 5656

  IFC Advisory (Financial PR and IR) Tim Metcalfe Graham Herring Florence Staton

  Tel: 0203 934 6632

  About Reach announcements This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  NRAPKBBNCBDDFBB